[The relationship between C-erbB-2 expression with cell proliferative activity and prognosis of nasopharyngeal carcinomas].
C-erbB-2 and proliferating cell nuclear antigen (PCNA) were detected by immunohistochemical and in situ hybridization methods in nasopharyngeal carcinomas(NPC) and pericarcinomatous tissues(PCT). Some NPC cases were followed up for more than 5 years. The positive rates of C-erbB-2 protein and C-erbB-2 mRNA expression were 87.8%, and 84.0%, respectively in NPC and 74.6% and 76.5%, respectively in PCT. There was a coexpression of C-erbB-2 protein and mRNA. The significant difference for PCNA staining intensity index(S II) existed in the vesico-nuclear and poorly differentiated types of NPC and in the C-erbB-2 staining cases of NPC. No correlation was found between the expression of C-erbB-2 protein and the clinical stage and metastasis as well as survival rate. The C-erbB-2 gene overexpression and cell abnormal proliferation are associated with the carcinogenesis and development of NPC. It is helpful to examine both C-erbB-2 gene expression and PCNA in NPC to evaluate the malignant degree and the effect of radiotherapy.